Nasal Polyps Treatment Market

Nasal Polyps Treatment Market Size (2023 to 2028)

The global nasal polyps treatment market size is estimated to grow from USD 2882 million in 2023 to USD 3785 million by 2028, growing at a CAGR of 5.6% from 2023 to 2028.

Polyps are growth tissues that most often look like small, flat bumps or tiny stalks that look like mushrooms. The polyps are mostly less than half an inch wide. Nasal polyps are soft, noncancerous growths on the lining of the nose or sinuses. They often occur in groups. They are soft and painless.  The medications used for the treatment of nasal polyps, like Dupilumab and corticosteroids, are known for suppressing immune response which might be a reason for COVID-19.

MARKET DRIVERS:

Increased awareness about nasal polyps due to public knowledge and education to public by healthcare professionals. Also, the topic has got media coverage through online resources. This increased awareness amongst the public is driving the nasal polyps treatment market.

New products like corticosteroids and agents like dupilumab and mepolizumab are entering the market. These enhance the efficacy of the treatment of nasal polyps, which exists already. These products drive the nasal polyps treatment market. Thus, increased awareness about the disease and the treatment options in the market and the easy availability of new drugs for nasal polyps are the major factors that drive the growth of the nasal polyp treatment market.

MARKET RESTRAINTS:

The medications used for the treatment of nasal polyps, like corticosteroids, can show side effects in some people, which include vomiting, giddiness, and headache. Due to this, many people refrain from using this medicine. This negatively affects the overall treatment for nasal polyps. These restrain the growth of the nasal polyp treatment market. Nasal polyps can be treated with medication in most of the cases. But in some of the patients, surgery needs to be done, which costs a hefty amount. Thus, some of the patients do not consider surgery as a feasible and affordable option. This acts as a restraint for the nasal polyps treatment market share to grow.

Nowadays, many new alternative options for treatment for nasal polyps are available. This includes herbal medications, dietary supplements, and acupuncture. However, these treatments are less effective as compared to surgery. Still, most people prefer it over surgery. Hence, the side effects of medicines, the high cost of surgery, and the availability of alternative treatments are the factors that limit the growth of the nasal polyps treatment market.

Impact of COVID-19 on the nasal polyps treatment market:

The COVID-19 pandemic had a negative impact on the nasal polyps treatment market. Due to the risk of getting infected with COVID-19, many people delayed the diagnosis and treatment of nasal polyps. The COVID-19 tests were given preference, due to which the tests and diagnosis for nasal polyps had been stopped at many healthcare centers. The test kits, medications, and other essentials for patients with nasal polyps were unavailable during the pandemic situation. Due to this, the surgeries had to be postponed or canceled.

During the COVID-19 outbreak, a new treatment method for nasal polyps that involves gene therapy has been developed. Basically, Gene therapy is a technique that modifies a person's genes to treat or cure a disease. For nasal polyps, gene therapy can affect the specific gene responsible for nasal polyps. Also, new surgery techniques have been developed that require less duration for recovery and are less invasive for the body. Thus, the nasal polyps treatment market has experienced a variety of situations during the outbreak of COVID-19. But, in the post-pandemic period, the market is gaining the market share back.

REPORT COVERAGE:

This research report on the global nasal polyps treatment market has been segmented and sub-segmented based on type, route of administration, distribution channel, and region.

Nasal Polyps Treatment Market – By Type:

• Corticosteroids
• Antibiotics
• Leukotriene Inhibitors

The corticosteroids segment is leading the nasal polyps treatment market with a market share of 52%. Corticosteroids effectively reduce the inflammation caused due to polyps. They are taken as oral medication and are useful for short-term relief.

The antibiotics segment stands second in the nasal polyps treatment market with a market share of 25%. Antibiotics are not used to treat the polyps but to relieve the symptoms associated with nasal polyps, like congestion, pain, and drainage.

Leukotriene inhibitors account for around 12.3% of the nasal polyp treatment market share. Leukotrienes are used for the inhibition of leukotriene which causes inflammations and results in the growth of nasal polyps.

Nasal Polyps Treatment Market – By Route of Administration:

• Oral
• Nasal

The nasal route of administration segment is leading the nasal polyps treatment market with a market share of more than 60%. As corticosteroids are the most used drug during the treatment of nasal polyps and they are available in the form of nasal sprays, drops, and rinses. Medications with the nasal route of administration also help to ease the airflow and treat polyps.

The oral route of administration of medicines used for nasal polyps is more effective than nasal drugs. Corticosteroids are the preferred drug for nasal polyps in oral form as well. But also has more side effects associated with them.

Nasal Polyps Treatment Market – By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

The retail pharmacies segment is leading the nasal polyps treatment market with a higher market share than the other distribution channels. Retail pharmacies are the most convenient mode of distribution of nasal polyp treatment drugs to patients. The distribution network is more dense in retail pharmacies than in hospitals or online pharmacies.

Hospital pharmacies stand second in the nasal polyp treatment market in the distribution channel. Hospital pharmacies are restricted to the distribution of medicines to specific hospital patients and customers.

The online pharmacies segment accounts for the lowest market share in the nasal drug treatment market. Lower consumer awareness about the segment in many regions restricts the growth of the online pharmacies segment. However, steady growth has been observed in the segment in recent times, especially in developed countries.

Nasal Polyps Treatment Market – By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

The region that is leading the nasal polyps treatment market is North America with a market share of 35%. The high demand for drugs associated with nasal polyps due to the rising number of citizens diagnosed with nasal polyps is the main reason for the growth of the nasal polyps treatment market in the region.

Europe accounts for 25% of the nasal polyps treatment market share. The extreme weather conditions in European countries at different times of the year severely affect the immune system, which results in varied kinds of infections in the nasal cavity which leads to conditions like nasal polyps and rhinosinusitis.

Asia Pacific region accounts for around 20% of the nasal polyps treatment market share and is also considered the fastest growing nasal polyps treatment market. The increasing prevalence of nasal polyps in patients in the region and the easy availability of drugs are the reasons for the rise in patients in the region.

Latin America and Middle East & Africa account for the lowest market share in the nasal polyps treatment market.

KEY MARKET PLAYERS:

Pfizer, Novartis AG, Sanofi, Merck & Co. Inc., Glaxo SmithKline plc, and Regeneron Pharmaceuticals are some of the major companies in the global nasal polyps treatment market.

RECENT MARKET DEVELOPMENTS:

• Regeneron got approval from the U.S. FDA for Dupixent, a product that has a base as Dupilumab.
• In July 2021, Glaxo SmithKline Plc got approval from the US FDA for its drug Nucala, which is used for nasal polyp treatment.